Nektar Therapeutics reported $7.67M in Cost of Sales for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Amgen AMGN:US $ 1637M 147M
Astrazeneca AZN:US 2.19B 273M
Baxter International BAX:US $ 1856M 75M
Biocryst Pharmaceuticals BCRX:US $ 0.34M 5.54M
Biogen BIIB:US $ 459.7M 18.4M
Bluebird Bio BLUE:US $ 15.3M 13.02M
Bristol Myers Squibb BMY:US $ 2451M 52M
Dr.Reddys Laboratories DRRD:IN 17.02B 1.61B
Eisai 4523:JP Y 39250M 1899M
Eli Lilly And LLY:US $ 1953.2M 74.6M
Esperion Therapeutics ESPR:US $ 1.8M 16K
Exelixis EXEL:US $ 14.88M 1.69M
Gilead Sciences GILD:US $ 1390M 29M
GlaxoSmithKline GSK:LN 2519M 108M
Halozyme Therapeutics HALO:US $ 23.02M 4.8M
Ironwood Pharmaceuticals IRWD:US $ 0M 0M
Karyopharm Therapeutics KPTI:US $ 1.14M 205K
MacroGenics MGNX:US 22K 5K
Merk MRK:US $ 2684M 771M
Nektar Therapeutics NKTR:US $ 7.67M 1.91M
Neurocrine Biosciences NBIX:US $ 3.1M 0.2M
Novartis NOVN:VX SF 3754M 79M
Pfizer PFE:US $ 6992M 2820M
Sarepta Therapeutics SRPT:US $ 19.52M 2.83M
Seattle Genetics SGEN:US $ 78.09M 13.96M
Takeda 4502:JP Y 241264M 12182M
Teva Pharmaceutical TEVA:IT 1.99B 76M
YTE INCY:US $ 32.63M 8.81M